Key indicators: single-crystal X-ray study; T = 293 K; mean (C-C) = 0.006 Å; R factor = 0.062; wR factor = 0.157; data-to-parameter ratio = 16.4.
In the title compound, C 19 H 26 N 2 2+ Á2Cl À , the piperazinediium ring exhibits a chair conformation. The dihedral angle between the two benzene ring planes is 76. 45 (13) . Both amine-group H atoms participate in hydrogen bonding with the two Cl atoms.
Related literature
The title compound was obtained in our search for a strong anti-Helicobacter pylori secondary metabolite. Table 1 Hydrogen-bond geometry (Å , ). 
Comment
The human pathogenic bacterium Helicobacter pylori has been ascertained to be an antiological agent for chronic active gastritis and a significant determinant in peptic and duodenal ulcer diseases (Gebert et al., 2003; Li et al., 2007) . Sustained infection with this bacterium could lead to development of gastric cancer (Moran & Upton, 1986) . Endophytic metabolites are recognized as a versatile arsenal of antimicrobial agents, since some endophytes have been shown to possess superior biosynthetic capabilities owing to their presumable gene recombination with the host, while residing and reproducing inside the healthy plant tissues. Our particular attention was extended to anti-Helicobacter pylori constituents. A detailed bioassayguided fractionation of the culture extract of Fusarium sp., an endophytic fungus in Quercus variabilis Bl., was performed to afford a strong anti-H. pylori secondary metabolite. In this paper we report the structural information for the title compound, et al., 1992; Ilangovan et al., 2007) . In the title compound, the piperazine fragment is in a chair conformation. The dihedral angle between the two benzene ring planes is 76.45 (13) °. Both amine-group H atoms participate in hydrogen bonding with the two Cl atoms.
Experimental
The cultivation of Fusarium sp. AMB-111, an endophytic fungus in Quercus variabilis, extraction and isolation were described in a preceding communication. A residue (149 g) from the dark brown tarry mass was obtained after depositing lipids, which was then subjected to column chromatography (CC) on silica gel (1300 g, 200-300 mesh), eluting with chloroform/methanol (1:0-0:1) to give seven fractions (F-1: 28.3 g, F-2: 12.2 g, F-3: 12.5 g, F-4: 14.0 g, F-5: 13.7 g, F-6: 12.3 g and F-7: 27.4 g). F-2, showing pronounced anti-Helicobacter pylori activity, was re-chromatographed over Si-gel column eluting with chloroform/acetone (50:1-4:1) to afford four subfractions (F-2-1: 4.5 g, F-2-2: 1.4 g, F-2-3: 2.3 g and F-2-4: 2.0 g). F-2-2 was subjected to gel filtration over Sephadex LH-20 with chloroform/methanol (1:1), followed by recrystalization repeatedly to give the title compound, a yellow crystal (300 mg).
Refinement
All H atoms were positioned geometrically (C-H = 0.93 Å for the aromatic H atoms and C-H = 0.96 Å for the aliphatic H atoms) and were refined as riding, with U iso (H) = 1.2U eq (C) and U iso (H) = 1.2U eq (N).
supplementary materials sup-2 Figures   Fig. 1 . The structure of the title compound showing 30% probability displacement ellipsoids and the atom-numbering scheme.
1-Diphenylmethyl-4-ethylpiperazine-1,4-diium dichloride
Crystal data /2θ scan h = 0→18 Absorption correction: ψ scan (North et al., 1968) k = 0→8 Fig. 1 
